Navigation Links
Avexa Reports Positive Phase IIb Result

VICTORIA, Australia--(BUSINESS WIRE)--Mar 20, 2007 - Australian biotechnology company Avexa (ASX:AVX) today announced highly successful results from its Phase IIb trial for apricitabine (ATC). ATC is Avexa's novel nucleoside reverse transcriptase inhibitor (NRTI) being developed for the treatment of HIV infection in patients with drug-resistant HIV.

The Phase IIb trial compared the effectiveness of ATC in reducing the viral load of patients with drug-resistant HIV with the effectiveness of lamivudine (3TC), a leading NRTI in widespread use. A total of 47 patients completed 21 day dosing. Of these 17 patients received 600 mg doses of ATC, 16 received 800 mg doses of ATC and the control group of 14 patients were treated with 3TC.

The results for patients in both ATC cohorts exceeded the Phase IIb trial primary endpoint by a substantial margin. Patients who received ATC achieved on average a reduction of greater than 0.8 log(10) (85%) in the level of HIV in the blood after 21 days treatment compared to a reduction of less than 0.03 log(10) in patients treated with 3TC. Nine patients achieved a greater than 1.5 log(10) (97%) reduction after 21 days, with 3 patients achieving a reduction of over 2.0 log(10) (99%). Remarkably, one patient achieved a decrease in the amount of virus of more than 2.5 log(10) (99.7%) after 21 days on ATC. Patients with the highest degree of drug resistance still achieved a significant benefit from treatment with ATC. The demonstration of superior activity in this study indicates that ATC will be an effective antiviral drug for the treatment of many drug-resistant patients, including even those most highly resistant.

"This is a fantastic result for Avexa," stated CEO Dr Julian Chick. "The positive result allows us to continue to progress ATC into Phase III trials and towards commercialisation. The team at Avexa has done a great job and these excellent results show that their
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Avexas Apricitabine Clinical Trial Update
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Avexa Reports Positive Phase IIb Result
(Date:5/22/2013)... , May 22, 2013 Z-Medica, a ... it has launched the first-ever line of products designed ... The line includes QuikClot ® EMS 4x4 Dressing, ... ® EMS Rolled Gauze™, all custom-designed to help ... they can be transported to a hospital or trauma ...
(Date:5/22/2013)... MANALAPAN, N.J. , May 22, 2013 ... this opportunity to update shareholders about some recent company ... will expand its avenues of communication with shareholders. Integrating ... has launched a Facebook page and will post updates ... the Twitter hashtag is #medifirstusa. Says ...
(Date:5/22/2013)... Mass. , May 22, 2013  Flagship ... firm focused on healthcare and sustainability, today announced ... as a Senior Partner. In this role, ... to portfolio companies. In addition to ... Mr. Bancel also serves as President and Chief ...
Breaking Medicine Technology:Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services 2Medifirst Solutions, Inc. Announces Update To Shareholders 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3
... 8 Transgenomic, Inc. (OTC Bulletin Board: TBIO). The ... mutation detection technology called Cold-PCR from the Dana-Farber Cancer ... standard PCR technology enriches mutations in DNA samples and ... level mutations in tissue and body fluids that are ...
... Pharmaceuticals, Inc. (Nasdaq: SVNT ) announced today the pricing ... stock at a price of $13.29 per share. After ... to receive net proceeds of approximately $52.9 million. All ... addition, Savient has granted the underwriters a 30-day option to ...
Cached Medicine Technology:Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute 2Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute 3Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute 4Savient Pharmaceuticals Prices Underwritten Offering of Common Stock 2
(Date:5/22/2013)... WEDNESDAY, May 22 (HealthDay News) -- Migraines and depression ... new research indicates the combination of the two may ... brain. , , Already aware that people with migraines ... determine if having both conditions together affected total brain ... -- isn,t alarming, study authors said, but needs further ...
(Date:5/22/2013)... York (PRWEB) May 22, 2013 Phelps ... established the Westchester Lung Nodule Center for individuals ... receive lung cancer care. Lung cancer is the deadliest form ... more people in the U.S. die from lung cancer than ... with all cancers, early detection increases survival rates. It ...
(Date:5/22/2013)... Registered Dietitian and Founder of Tatalou Science Nathalie ... a recipe for making energy bars at home. , The ... takes a recipe modified from one recently featured on ... it gets more and more difficult to understand what ingredients ... of the nutrition label continues to grow and consumers are ...
(Date:5/22/2013)... Georgia (PRWEB) May 22, 2013 HR ... event, hosted at the Gwinnett County Fairgrounds, on Friday ... company before, they far surpassed expectations; raising over $6,300 ... corporate sponsor for the event, donating the first $3,000 ... Beesley , challenged the internal staff to match the ...
(Date:5/22/2013)... 2013 Go Classy the Original Nudist ... launch of their newest website http://www.Desire-Mexico.com . The ... minds, Desire Resorts have become the premier Nudist and ... of total liberation while allowing you to enjoy a ... Go Classy Tours / Caribbean-Hideaways. He goes on to ...
Breaking Medicine News(10 mins):Health News:Having Both Migraines, Depression May Mean Smaller Brain 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 3Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3Health News:How To "Make Your Own Healthy Energy Bars" 2Health News:HR Strategies Raises Over $6,300 for Cancer Research via Relay For Life 2Health News:Go Classy Tours Announces the Launch of Their Newest Website for Desire Resorts Located in Mexico Clothing Optional/Aunaturel Resorts a Lovers Paradise 2
... 26 Nutrisystem, Inc. (Nasdaq: NTRI ), a ... announced a new multi-year alliance with the American Diabetes ... and the public about the importance of weight loss ... the relationship, Nutrisystem will support the Association,s efforts to ...
... WASHINGTON , Oct. 26 America,s ... Ignagni, President and CEO: , "A new government-run plan would underpay ... costs and improve quality. The American people want health care ... , "The divisive debate about a government-run plan is ...
... of severe physical, psychosocial suffering, researchers say , MONDAY, ... World War II, those who were potentially exposed to ... due to physical and mental stress, an Israeli study ... rates in more than 300,000 Israeli Jews who were ...
... But healthy habits can stave off the inevitable declines, research ... in fitness that accompany growing old typically speed up after ... But people can slow the inevitable by staying lean, exercising ... Oct. 26 issue of the Archives of Internal Medicine ...
... doubled risk of GERD, may be linked to mental fallout ... rescue workers can add another illness to the list of ... Zero toxins and the ensuing mental anguish of the tragedy ... shows that 41 percent of World Trade Center responders have ...
... , PLANO, Texas, Oct. 26 Perot Systems Corporation (NYSE: ... an agreement with China Telecommunications Corporation (China Telecom) in which ... information technology (IT) solutions for the healthcare industry in China. ... to develop and go to market with an e-health platform ...
Cached Medicine News:Health News:Nutrisystem and the American Diabetes Association Form a Strategic Alliance to Promote the Importance of Weight Loss for People With Type 2 Diabetes 2Health News:Nutrisystem and the American Diabetes Association Form a Strategic Alliance to Promote the Importance of Weight Loss for People With Type 2 Diabetes 3Health News:AHIP Statement on Government-Run Plan 2Health News:AHIP Statement on Government-Run Plan 3Health News:Exposure to Holocaust May Have Raised Cancer Risks 2Health News:Fitness Fades Fast After 45 2Health News:Fitness Fades Fast After 45 3Health News:World Trade Center Workers Have More Cases of Acid Reflux 2Health News:World Trade Center Workers Have More Cases of Acid Reflux 3Health News:Perot Systems Announces Strategic Alliance With China Telecom 2Health News:Perot Systems Announces Strategic Alliance With China Telecom 3
... All Infectious Disease ELISA ... well format. Also included ... positive and negative controls, ... stop solution. Use an ...
... polymerase chain reaction (PCR) technology, the worlds ... essential component of Roches blood screening assays ... amounts of selected unique regions of genetic ... copies (that is, to detectable levels) in ...
... in New Technology, the Arrow International AutoCAT ... first and only IABP system that uses ... based timing algorithm, WAVE, to deliver beat ... Second generation Automaticity provides for sophisticated hands-off ...
... IHC, the worlds first truly ... system introduced a whole new ... combining system modularity and ease ... productivity. The NexES Systems automated ...
Medicine Products: